Back to MW MARSHALL WACE, LLP

ALDXALDX
Showing 4 of 10 quarters

Position history for MWMARSHALL WACE, LLP's holdings in ALDEYRA THERAPEUTICS INC

MARSHALL WACE, LLP holds 1.5M shares of ALDX (ALDEYRA THERAPEUTICS INC), worth $3.2M as of 2026-Q2. The position was increased (+1062.0% shares). ALDX represents 0.0% of MARSHALL WACE, LLP's portfolio.

Current Value

$3.2M

Current Shares

1.5M

Total Value Change

+$2.4M

Total Shares Change

+1.3M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.5M
+1062.0%
$3.2M0.0%$2.13
43
2026-Q1
New
129,693
-
$219,1810.0%$5.11
32
2025-Q4
Exited
0
-100.0%
$00.0%$5.15
0
2025-Q3
New
160,213
-
$836,3120.0%$5.21
34

Other major holders of ALDX: BNP PARIBAS FINANCIAL MARKETS, Verition Fund Management LLC, BlackRock, Inc., VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used